The Changing Face of Pharmacovigilance and Drug Safety Compliance and Inspections: Implications and Best Practices for Companies Marketing Drugs in EU

Instructor: Dr. Elliot Brown
Product ID: 700081
Training Level: Intermediate to Advanced
  • Duration: 60 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

The relevant EU legislation and the new guidelines on monitoring and compliance. Findings from recent EU inspections and from independent audits carried out by the presenter over the last 5 years are presented and discussed.


This seminar looks at the changing face of pharmacovigilance inspection worldwide being dictated by practices originating in the European Union.

It focuses on the implications for companies currently marketing medicines in the EU, or with aspirations to do so. The webinar will summarise the relevant EU legislation and the new guidelines on monitoring and compliance. Findings from recent EU inspections and from independent audits carried out by the presenter over the last 5 years will be presented and discussed.

Areas Covered in the Seminar:

  • New EU regulations and guidelines on pharmacovigilance
  • New compliance and monitoring guidelines in Europe
  • What to expect in an EU pharmacovigilance inspection – when carried out within Europe, the US or elsewhere
  • Findings from EU inspections
  • Findings from independent audits
  • Implications for companies large and small with EU products
  • Interactions between EU and US agencies
  • What the future holds?

Who Should Attend:

  • Compliance officers of companies with drugs or biological products on the market in the EU
  • Regulatory affairs staff of companies with contractual arrangements with third parties with products on the market in the EU (service provision or licensing agreements)
  • Executives of companies planning to apply for marketing authorization in the EU
  • Managers working in pharmacovigilance, quality assurance, system and IT support, legal affairs

Instructor Profile:

Dr. Elliot Brown, trained and worked as a family physician, then spent 10 years in senior positions in various companies. He was an assessor (reviewer) for 5 years at the UK regulatory authority (MHRA) and was UK representative on the EMEA’s CPMP Pharmacovigilance Working Party, the principal drug safety assessment and rule-making body in the EU. He was EU representative on the ICH M1 (MedDRA) Expert Working Group, a member of the WHO Uppsala Monitoring Centre signal review panel and a founding member of the CIOMS working group on Standardised MedDRA Queries.

For the last 7 years, Dr.Brown has been Managing Director of Elliot Brown Consulting, an international firm of consultants specialising in pharmacovigilance / risk management / regulatory compliance. He has performed many independent pharmacovigilance audits for companies large and small in 4 continents.

Dr. Brown holds an Honorary Senior Lecturer position at the University of London’s School of Hygiene and Tropical Medicine. He is a member of the Editorial Boards of the journals Drug Safety, Current Drug Safety and the International Journal of Pharmaceutical Medicine and has published extensively on pharmacovigilance and associated topics as well as chairing and speaking at numerous international conferences.

Follow us :
Seminars by Ex-FDA Officials
Critical Vendor Risk Management

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed